Three New Early-Stage Investors Attending RESI JPM for First Time

By Momo Yamamoto, Investor Research Analyst, LSN

Life Science Nation(LSN) recently hosted a webinar with three investors that will be attending RESI for the first time at the upcoming RESI JPM, in-person on Tuesday, January 9 at the Marines’ Memorial Hotel followed by virtual partnering, January 10-11. LSN is pleased to introduce James Feng, Partner of MSA Capital, Leah Villegas, Managing Partner of Aquillius Ventures, and Matias Serebrinsky, Co-Founder and General Partner of PsyMed Ventures. This webinar provides insight into the different focuses in early-stage innovation spaces.

 Life Science Nation’s research team works continuously not only to add new investor attendees to our RESI conferences but also integrate them into our early-stage ecosystem. These investors will be part of our investor database and we look forward to fostering relationships between them and the companies in our ecosystem that are a fit for their investment mandate. PsyMed Ventures joins RESI with a lens on mental health and more specifically “frontier technologies” and how they define this concept.  MSA Capital is an international firm with an arm in healthcare based in China and investing in seed to series B, writing checks between $1-25M. James, with MSA, provides insight into their interest in early-stage companies tackling aging-related diseases. Aquillius Ventures is the investment arm of their innovation hub located in San Diego, and is looking to connect with innovative biotech and medical device companies. Their main fund does not require companies to go through their accelerator program and offers a wide range of resources. 

Thank you to these investors for their time and informative discussion on what they hope to accomplish next month at RESI JPM and what they are looking for when building relationships with early-stage startups. We are excited to have them join us at RESI. Click here to access the full video.  

Leah Villegas, Managing Partner, Aquillius Ventures

Aquillius Ventures is the venture arm of Aquillius, an innovation hub headquartered in San Diego, CA for life science, medtech, and technology companies. The firm invests in Pre-Seed and Seed stage biotech, device, and ag-tech companies in the U.S.

James Feng, Partner, MSA Capital

MSA Capital is a global investment firm founded in 2014 and headquartered in Beijing, China that focuses on private venture and growth assets. The firm manages over $2B USD and invests in highly innovative and disruptive companies in the biotechnology, enterprise-facing core technology, and consumer sectors.

Matias Serebrinsky, Co-Founder & General Partner, PsyMed Ventures

PsyMed Ventures is a venture capital fund founded in 2020 and headquartered in San Francisco, CA. The firm invests in Pre-Seed and Seed life science and healthcare companies that focus on mental health and wellness.